Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,601–1,700 of 3,349
Lv, J., Chen, L., Zhu, N., Sun, Y., Pan, J., Gao, J., Liu, J., Liu, G., & Tao, Y. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00613-3 · Cited by 18
APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid1
Berger, M., Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszeski, J. L., VanDusen, K. W., Thompson, J. W., Moseley, M. A., Devinney, M. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200747 · Cited by 15
Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development
Heider, J., Vogel, S., Volkmer, H., & Breitmeyer, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910254 · Cited by 26
“Accordingly, mouse models proved that inhibition of C1q or C3 reduced microglia-mediated synapse loss and revealed aberrant synaptic elimination e.g., in a mouse model for Alzheimer’s Disease [43].”
BackgroundYuyama, K., & Igarashi, Y. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10066-8 · Cited by 23
“APP transgenic mice used in this study exhibited deficits in spatial memory, alongside neuronal inflammation and synaptic loss due to the high expression of Aβ [48, 49].”
MethodMakrakis, D., Holt, S. K., Bernick, C. B., Grivas, P. D., Gore, J. L., & Wright, J. L. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000530 · Cited by 20
The antipsychotic landscape: dopamine and beyond
Morrison, P. D., & Murray, R. M. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317752915 · Cited by 19
Shabir, O., Sharp, P. S., Rebollar, M. A., Boorman, L. W., Howarth, C., Wharton, S. B., Francis, S., & Berwick, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64334-4 · Cited by 20
Rosi, S. (2018) · Brain Circulation · doi:10.4103/bc.bc_24_18 · Cited by 18
“These studies indicated that the inhibition of C1q or C3 attenuates synapse loss in Alzheimer’s models.[15,16] Similar to these reports, we and others have demonstrated”
ResultLi, M., Ma, Y., Guo, Y., Liu, J.-Y., Tan, L., & Initiative, O. B. O. A. D. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01377-5 · Cited by 20
“One study found complement-dependent pathways and microglia, which were inappropriately activated, mediated early synaptic loss in AD [41], and another study found the inhibition of C1q impaired classical complement cascade processes, thereby reducing glial activation and synaptic loss [42].”
The role of neuroglial cells communication in ischemic stroke
Yu, Y., Liao, X., Xie, X., Qihua, L., Chen, X., & Liu, R. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110910 · Cited by 22
“…motif receptor 1 (CX3CR1) interaction, which prevents excessive pruning associated with conditions like Alzheimer's disease (AD) and schizophrenia [33, 34] . n r Studies have shown that oxygen-glucose deprivation/reoxygenation (ODG/R) injury to neurons leads to the release of neuronal…”
Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis
Ray, A., Loghinov, I., Ravindranath, V., & Barth, A. L. (2024) · iScience · doi:10.1016/j.isci.2024.110629 · Cited by 18
Sandoval, C., Lee, J., Toth, B., Nagaraj, R., Schauer, S. P., Hoffman, J. C., Calderon, E., Kollmorgen, G., Bohorquez, S. M. S., Monteiro, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14271 · Cited by 19
“6,7 9 There is thus a growing interest to further characterize complement activation and evaluate complement-targeting therapeutics in AD.”
Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
Plano, L. M. D., Saitta, A., Oddo, S., & Caccamo, A. (2024) · Biomolecules · doi:10.3390/biom14111405 · Cited by 22
“Specifically, Wright and colleagues reported a ~10% reduction in CA1 neuronal numbers at 3 months, which increased to ~20% at 6 months and ~30% at 9 months [63].”
InfluentialMeng, D., Lai, Y., Zhang, L., Hu, W., Wei, H., Guo, C., Jing, X., Zhou, H., Xiao, R., Zhu, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07125-1 · Cited by 21
Yang, X., Wang, Y., Qiao, Y., Lin, J., Lau, J. K. Y., Fu, W., Fu, A. K. Y., & Ip, N. Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420324122 · Cited by 22
Freiwald, T., & Afzali, B. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188350 · Cited by 23
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 25
“On the other hand, their chronic activation can lead to detrimental outcomes, such as excessive synaptic pruning mediated by the complement pathway [69,70] and the release of reactive oxygen species (ROS) [71] and pro-inflammatory cytokines like TNF-α , which exacerbate neuronal damage [72].”
Microglia across evolution: from conserved origins to functional divergence
Shimizu, T., & Prinz, M. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01368-6 · Cited by 30
“The activation of downstream complement components such as C3 subsequently drives excessive synaptic pruning by microglia, resulting in cognitive decline [225].”
Goodwani, S., Fernandez, C., Acton, P. J., Buggia-Prévot, V., McReynolds, M. L., Ma, J., Hu, C. H., Hamby, M. E., Jiang, Y., Le, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144849 · Cited by 20
Lin, Y.-S., Liu, C., Lee, H., Chou, M., Ke, L., Chen, C., & Chen, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-85502-0 · Cited by 16
Actin-dependent astrocytic infiltration is a key step for axon defasciculation during remodeling
Marmor‐Kollet, N., Berkun, V., Cummings, G., Keren‐Shaul, H., David, E., Addadi, Y., & Schuldiner, O. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112117 · Cited by 19
Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
Drew, V. J., Wang, C., & Kim, T. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119810 · Cited by 20
Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease
Hay, A. J. D., Latham, A. S., Mumford, G., Hines, A. D., Risen, S. J., Gordon, E., Siebenaler, C., Gilberto, V. S., Zabel, M. D., & Moreno, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1158408 · Cited by 18
“Mesenchymal stromal cells (MSCs) have been used in mouse models of neurodegenerative diseases such as Alzheimer’s and Parkinson’s (Chen et al., 2017, 2020; Hu and Wang, 2021; Peng et al., 2022).”
MethodGuan, P.-P., Ge, T.-Q., & Wang, P. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10076-9 · Cited by 21
“1 3 the number of phagocytic microglia and the extent of early synapse loss, suggesting that C1q is necessary for the toxic effects of soluble Aβ oligomers on synapses and hippocampal long-term potentiation (Hong et al. 2016).”
BackgroundInfluentialKamalian, A., Ho, S. G., Patel, M. A., Lewis, A., Bakker, A., Albert, M., O’Brien, R., Moghekar, A., & Lutz, M. W. (2023) · Biomolecules · doi:10.3390/biom13071094 · Cited by 18
Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
Eugenín, J. L., Bernhardi, L. E.-V., & Rommy von Bernhardi, M. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1249320 · Cited by 20
Whiteside, D. J., Holland, N., Tsvetanov, K. A., Mak, E., Malpetti, M., Savulich, G., Jones, P. S., Naessens, M., Rouse, M. A., Fryer, T. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44307-7 · Cited by 19
“Group differences in synaptic density, neurite dispersion, connectivity, and grey matter There were widespread signi fi cant reductions in [ 11 C]UCB-J BP ND , the orientation dispersion index (ODI) determined with NODDI, grey matter volume, and weighted degree in patients compared to control…”
BackgroundMethodInfluentialSinghaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105724 · Cited by 21
“A potential role for CTRP3 in AD remains to be explored in the future, but Hong et al. have shown that inhibition of C1q, C3, or the microglial complement receptor, CR3, reduces phagocytic microglia and synapse loss (Hong et al., 2016).”
BackgroundYang, L., Wu, J., Zhang, F., Zhang, L., Zhang, X., Zhou, J., Pang, J., Xie, B., Xie, H., Jiang, Y. Q., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114853 · Cited by 20
CSMD1 as a causative gene of developmental and epileptic encephalopathy and generalized epilepsies
Zhang, W., Luo, S., Jiang, M., Chen, Y., Ren, R., Wu, Y., Wang, P., Zhou, P., Qin, J., & Liao, W. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101473 · Cited by 18
“38,39 Additionally, it acts like neuropilin and neuronal growth cone proteins, playing a vital role in guiding axons toward synaptic targets and signal transduction during development.”
Deciphering microglial diversity in Alzheimer's disease
Brown, G. C., & George‐Hyslop, P. S. (2017) · Science · doi:10.1126/science.aan7893 · Cited by 18
Szakács, D., Kocsis, A., Szász, R., Gál, P., & Pál, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008315 · Cited by 20
“The CP participates in Alzheimer’s disease (13) and myasthenia gravis (14), the LP contributes to IRI of various tissues (15–18), and the AP plays a significant role in age-related macular degeneration (19) and atypical hemolytic uremic syndrome (20).”
BackgroundSepulveda‐Rodriguez, A., Li, P., Khan, T., Ma, J. D., Carlone, C. A., Bozzelli, P. L., Conant, K. E., Forcelli, P. A., & Vicini, S. (2019) · eNeuro · doi:10.1523/eneuro.0056-19.2019 · Cited by 20
“…pro-inflammatory or anti-inflammatory signaling, microglia have distinct and well-established roles in critical components of development (Stevens et al., 2007; Tremblay et al., 2010), physiology (Tremblay et al., 2011; Schafer et al., 2013), and pathology (Hong et al., 2016; Vasek et al., 2016).”
BackgroundNeuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 19
Roda, A. R., Montoliu‐Gaya, L., Serra-Mir, G., & Villegas, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186630 · Cited by 19
“It has been reported that both complement and microglia mediate synaptic loss [55], that some variants of TREM2 increase the risk for developing AD [56], and that there are astroglial and microglial reactive cells surrounding Aβ plaques [57].”
BackgroundAn antibody to RGMa promotes regeneration of cochlear synapses after noise exposure
Nevoux, J., Alexandru, M., Bellocq, T., Tanaka, L., Hayashi, Y., Watabe, T., Lahlou, H., Tani, K., & Edge, A. S. B. (2021) · Scientific Reports · doi:10.1038/s41598-021-81294-5 · Cited by 18
Advances in Proteomics Allow Insights Into Neuronal Proteomes
Fingleton, E., Li, Y., & Roche, K. W. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.647451 · Cited by 19
Impact of dietary polyphenols on neuroinflammation-associated disorders
Revi, N., & Rengan, A. K. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05303-1 · Cited by 19
Wei, W., Liu, Y., Dai, C., Baazaoui, N., Tung, Y. C., Liu, F., & Iqbal, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201599 · Cited by 17
Towards developing a rhesus monkey model of early Alzheimer's disease focusing on women's health
Beckman, D., & Morrison, J. H. (2021) · American Journal of Primatology · doi:10.1002/ajp.23289 · Cited by 19
“In a series of studies, a protein complex highly expressed in the microglia, the complement component 1q (or simply C1q), is responsible for AβO‐mediated synaptotoxicity very early in the progression of AD pathology in mouse models (Hong et al., 2016).”
BackgroundMicroglia, synaptic dynamics and forgetting
Wang, C., Wang, L., & Gu, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.005 · Cited by 20
TSPO regulation in reactive gliotic diseases
McNeela, A. M., Bernick, C. B., Hines, R. M., & Hines, D. J. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24212 · Cited by 23
“The immune response to damaged tissue is well characterized throughout the body and involves various signaling cascades during the progression of a disease or injury (Hamby et al., 2012; Hotamisligil, 2006; Kotas & Medzhitov, 2015).”
BackgroundXu, R., Boreland, A. J., Li, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.09.331710 · Cited by 17
Progress in the mechanisms of pain associated with neurodegenerative diseases
Tian, Z., Zhang, Q., Wang, L., Li, M., Li, T., Wang, Y., Cao, Z., Jiang, X., & Luo, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102579 · Cited by 18
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 25
“In mouse models of AD, activation of the complement system was found to precede the formation of amyloid plaques (195), and the fi nding that microglia are involved in synaptic loss through a complement-mediated mechanism underscores the importance of the complement system in the early pathological…”
Gao, R., Gao, Y., Su, W., & Wang, R. (2025) · Aging and Disease · doi:10.14336/ad.2024.1629 · Cited by 35
d’Errico, P., Früholz, I., Meyer‐Luehmann, M., & Vlachos, A. (2025) · Brain stimulation · doi:10.1016/j.brs.2025.03.012 · Cited by 21
Slayo, M., Rummel, C. D., Singhaarachchi, P. H., Feldotto, M., & Spencer, S. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00824-1 · Cited by 21
“…brain [45] Increases vascular permeability in the brain [46] Increases pro-inflammatory microglial phenotype [43] with synaptotoxic, soluble oligomers of amyloid-β engulf synapses even before plaques form yet blocking this process by inhibition of complement receptor CR3 rescues synaptic loss [69].”
Liu, X., Wang, H., Tian, X., Luo, Y., Ma, M., Zheng, Z., Wang, Y., Feng, S., Wang, Q., Xu, Z. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03488-2 · Cited by 21
Xie, M., Liang, Y., Miller, A. S., Pallegar, P. N., Umpierre, A. D., Wang, N., Zhang, S., Nagaraj, N. K., Fogarty, Z. C., Ghayal, N. B., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.08.016 · Cited by 29
Kalovyrna, N., Apokotou, O., Boulekou, S., Paouri, E., Boutou, A., & Georgopoulos, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65378-2 · Cited by 17
Autophagy Pathways in CNS Myeloid Cell Immune Functions
Keller, C. W., Münz, C., & Lünemann, J. D. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.09.003 · Cited by 17
Insights Into Central Nervous System Glial Cell Formation and Function From Zebrafish
Neely, S. A., & Lyons, D. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754606 · Cited by 19
“Synapse-associated microglia express the complement gene C1qc, a known protein which also regulates synaptic engulfment by microglia in rodents (Stevens et al., 2007; Hong et al., 2016), which could suggest that it may mediate similar functions in the zebrafish.”
BackgroundXu, X., Zhang, J., Li, S., Al‐Nusaif, M., Zhou, Q., Chen, S., & Le, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.788730 · Cited by 20
Self-citationYeap, J., Sathyaprakash, C., Toombs, J., Tulloch, J., Scutariu, C., Rose, J. L., Burr, K., Davies, C., Colom‐Cadena, M., Chandran, S., et al. (2022) · Brain and Neuroscience Advances · doi:10.1177/23982128221086464 · Cited by 16
“…and K+ efflux are also prerequisites for the formation of microglial and astrocytic inflammasomes (Venegas & Heneka, Michael, 2019), and data are accumulating linking both microglia and astrocytes to synapse loss in AD models (Henstridge et al., 2019; S. Hong et al., 2016; Litvinchuk et al., 2018).”
BackgroundEyolfson, E., Carr, T. H., Fraunberger, E. A., Khan, A. C., Clark, I., Mychasiuk, R., & Lohman, A. W. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114172 · Cited by 20
C1q as a target molecule to treat human disease: What do mouse studies teach us?
Schulz, K., & Trendelenburg, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958273 · Cited by 17
“Mainly neurological disease entities were tackled with main effects being shown on microglia: from potential synaptic rescue in transgenic Tau-P301S AD model mice (179) as well as wt mice challenged with intraventricular injection of soluble amyloid b oligomers (21) and neurolupus (180) to effects on microglia as a th…”
BackgroundSchröder, S., Heck, J., Groh, A., Frieling, H., Bleich, S., Kahl, K. G., Bosch, J. J., Krichevsky, B., & Westhoff, M. S. (2022) · Brain Sciences · doi:10.3390/brainsci12111424 · Cited by 16
Patil, G. V., Kulsange, S. E., Kazi, R. S., Chirmade, T., Kale, V., Mote, C., Aswar, M. K., Koratkar, S., Agawane, S. B., & Kulkarni, M. J. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00143 · Cited by 15
β-Glucan alleviates goal-directed behavioral deficits in mice infected with Toxoplasma gondii
Cui, Z., Gong, Y., Luo, X., Zheng, N., Tan, S., Liu, S., Li, Y., Wang, Q., Sun, F., Hu, M., et al. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-05686-4 · Cited by 17
“It is important to note that neurodegenerative diseases such as AD are often characterized by the development of neuroinflammation in the CNS, structural damage to neuronal structures and loss of messaging function within the brain, as well as damage to synaptic ultrastructure and synaptic dysfunction [42].”
BackgroundExtracellular vesicles: A new communication paradigm of complement in neurological diseases
Gu, X., Chen, A., Su, Y., You, M., Guo, H., Tan, S., He, Q., & Hu, B. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110667 · Cited by 18
Wang, Y., Wu, T. Z., Tsai, M., Rezzonico, M. G., Abdel‐Haleem, A. M., Xie, L., Gandham, V. D., Ngu, H., Stark, K. L., Glock, C., et al. (2023) · eLife · doi:10.7554/elife.83451 · Cited by 18
“, 2019), complement pathway activation (Dejanovic et al., 2018; Hong et al., 2016; Wu et al., 2019), and infiltration of T- cells (Gate et al.”
BackgroundMartín‐Flores, N., Podpolny, M., McLeod, F., Workman, I., Crawford, K., Ivanov, D. K., Leonenko, G., Escott‐Price, V., & Salinas, P. C. (2024) · eLife · doi:10.7554/elife.89453 · Cited by 30
Hinkle, J. J., Olschowka, J. A., Williams, J. P., & O’Banion, M. K. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.12.017 · Cited by 17
Astrocytes Excessively Engulf Synapses in a Mouse Model of Alzheimer’s Disease
Li, L., Lü, S., Zhu, J., Yu, X., Hou, S., Huang, Y., Niu, X., Du, X., & Liu, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021160 · Cited by 18
“All animal experiments were approved by the Institutional Animal Care and Use Committee of Tsinghua University, and adhered to the Guide for the Care and Use of Laboratory Animals of the Chinese Association for Laboratory Animal Science.”
BackgroundMethodWang, M., Sun, P., Chai, X., Liu, Y., Li, L., Zheng, W., Chen, S., Zhu, X., & Zhao, S. (2024) · Theranostics · doi:10.7150/thno.99468 · Cited by 21
“Studies have documented postsynaptic density protein-95 positive (PSD95 + ) puncta, which serve as a marker of excitatory synapses, as a synaptic element in microglia-mediated synaptic engulfment [32].”
BackgroundChen, P., Wu, L., Lei, J., Chen, F., Feng, L., Liu, G., & Zhou, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113151 · Cited by 19
Xu, J., Song, W., Xu, Z., Danziger, M. M., Karavani, E., Zang, C., Chen, X., Li, Y., Paz, I. R., Gohel, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14373 · Cited by 20
Myeloid lineage C3 induces reactive gliosis and neuronal stress during CNS inflammation
Garton, T. P., Smith, M. D., Kesharwani, A., Gharagozloo, M., Oh, S., Na, C. H., Absinta, M., Reich, D. S., Zack, D. J., & Calabresi, P. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58708-3 · Cited by 18
“Co-localization of elevated levels of C3 onto synapses during in fl ammation has led to the hypothesis that elevated complement may be aberrantly opso-nizing synapses 7,20,21 , leading to excessive synaptic damage and subsequent neuronal death.”
Roeper, J. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.09.007 · Cited by 20
Zhao, Y., Pu, D., Sun, Y., Chen, J., Luo, C., Wang, M., Zhou, J., Lv, A., Zhu, S., Liao, Z., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.030 · Cited by 16
Toedebusch, C. M., Snyder, J. C., Jones, M. R., Garcia, V. B., Johnson, G. C., Villalón, E., Coates, J. R., & Garcia, M. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.01.009 · Cited by 17
Liang, L., Mao, S., Wang, J., Ding, X., & Zen, J. (2019) · ExRNA · doi:10.1186/s41544-019-0031-z · Cited by 20
“Recently, it is observed that there are microglia mediated synaptic structure loss in several neurological disease model including Alzheimer’s disease, multiple sclerosis and lupus, which further emphasizes the significance of microglia in the pathogenesis of CNS disorders [2, 20, 36, 42].”
BackgroundQuarta, A., Berneman, Z. N., & Ponsaerts, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0820-536r · Cited by 17
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 16
“Also, in the APPPS1- 21 animal model, total removal of TREM2 caused reduction in Aβ accumulation in the mice cortex that are 2 months of age, whereas the accumulation increased in the mice cortex who are 8 months in age (Jay et al., 2017).”
MethodPotential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Liu, X., Zhang, N., Zhang, S., & Xu, P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15502 · Cited by 17
“Aβ has strong neurotoxicity and induces a severe inflammatory response in the brain, which is thought to be responsible for initiating the pathological cascade of AD (Elmaleh et al., 2019; Hong et al., 2016).”
BackgroundRosenthal, S. B., Wang, H., Shi, D., Liu, C., Abagyan, R. A., McEvoy, L. K., & Chen, C. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009903 · Cited by 19
SIRPα deficiency accelerates the pathologic process in models of Parkinson disease
Wang, J., Ding, X., Wu, X., Liu, J., Zhou, R., Wei, P., Zhang, Q., Zhang, C., Zen, K., & Li, L. (2019) · Glia · doi:10.1002/glia.23689 · Cited by 20
“Several studies revealed such pathway is also activated in the synapse loss in AD as well as lupus pathology (Hong et al., 2016; Presumey, Bialas, & Carroll, 2017).”
BackgroundLana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
Neural changes in Alzheimer’s disease from circuit to molecule: Perspective of optogenetics
Yang, Q., Song, D. F., & Qing, H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.015 · Cited by 16
A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease statesPreprint
Dräger, N. M., Sattler, S. M., Huang, C. T.-L., Teter, O. M., Leng, K., Hashemi, S. H., Hong, J. Y., Aviles, G., Clelland, C. D., Zhan, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448639 · Cited by 16
The alteration and role of glycoconjugates in Alzheimer’s disease
Kang, Y., Zhang, Q., Xu, S., & Yu, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1398641 · Cited by 17
“In AD, the complement-dependent pathway is abnormally activated, leading to synapse loss (Hong et al., 2016).”
BackgroundWood, L. B., & Singer, A. C. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110122-120158 · Cited by 17
Shan, S., Cheng, D., Li, H., Yao, W., Kou, R., Ji, J., Liu, N., Zeng, T., & Zhao, X. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137615 · Cited by 20
Hu, W., Chen, M., Lin, Y., Zhang, H., Sun, L., Shao, W., Ye, Y., Cheng, Y., Zhou, S., Hu, P., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01378-x · Cited by 20
“Both human and animal studies have also demonstrated possible links between synaptic pruning dysfunctions by microglia and the mechanisms of neuropsychiatric disorders [8–14], particularly autism spectrum disorder (ASD) [15] and Alzheimer’s disease (AD) [16, 17].”
Guo, F., Sheng, Z.-H., Fu, Y., Wang, Z., Xue, R., Tan, L., Tan, M., & Wang, Z.-T. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03458-5 · Cited by 25
“Additionally, C1q is necessary maintaining prolonged synaptic strengthening in the hippocampus and the deleterious effects of soluble A β oligomers on synapses [16].”
InfluentialImpaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease
Ebrahimi, R., Golzari, Z., Heidari‐Foroozan, M., Khosravi, A., Sharghi, S. G., Saleh, M., Salarvandian, S., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01712-9 · Cited by 23
“Notably, TREM2 is overexpressed in DAM and MGnD phenotypes near Aβ plaques (Keren-Shaul et al. 2017), sug‑ gesting a role in synaptic elimination via the complement pathway (Hong et al. 2016).”
cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities
Fazal, F., Dar, N. J., Ahamad, S., Khan, S., Bano, N., Saha, S., Nazir, A., & Bhat, S. A. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101444 · Cited by 24
Microglia and neuroinflammation: function, heterogeneity, and crosstalk
Zong, S., Cui, X., Wu, S., & Lu, Z. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01438-3 · Cited by 30
“Consequently, the classical complement cascade initiated by C1q plays a central role in the global coordination of neuroin fl ammation within the CNS. C1q forms complexes with A β [140] and phosphorylated tau [141], triggering the classical complement activation pathway.”
Synapse-specific roles for microglia in development: New horizons in the prefrontal cortex
Blagburn-Blanco, S. V., Chappell, M. S., Biase, L. M. D., & DeNardo, L. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.965756 · Cited by 16
Feng, L., Lo, H., You, H., Wu, W., Cheng, X., Xin, J., Ye, Z., Chen, X., & Pan, X. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114230 · Cited by 16
Zhuang, J., Zhang, Y., Shu, H., Zhang, S., Zhao, W., Ward, N., & Wang, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03133-6 · Cited by 19
Nheu, D., Ellen, O., Ye, S., Öztürk, E., Pagnin, M., Kertadjaja, S., Theotokis, P., Grigoriadis, N., McLean, C., & Petratos, S. (2022) · Cells · doi:10.3390/cells11233768 · Cited by 17
Li, S.-M., Liu, H., Qian, Y., Jiang, L., Liu, S., Liu, Y., Liu, C., & Gu, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109479 · Cited by 15
Self-citationThe biological alterations of synapse/synapse formation in sepsis-associated encephalopathy
Tang, C., Ye, J., & Wang, H. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.1054605 · Cited by 18
“The complement C3 which cleavage product C3a binds to the G protein-coupled receptor of C3a receptor (C3aR) is the central molecule of the complement system and plays a pivotal role in the immune system (Lian et al., 2015; Hong et al., 2016; Lohman et al., 2017).”
BackgroundLi, M., Sun, C., Xue, S., Leng, B., Sun, H., Shen, T., Liu, X., Li, Z., Shang, X., & Zhang, J. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10412 · Cited by 16
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration
Zhang, S., Meng, R., Jiang, M., Qing, H., & Ni, J. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230203103910 · Cited by 16
“Microglial chronic activation may result in phagocytosis of endothelial cells or astrocytic endfeet [62, 67], leading to BBB damage and the loss of synapses [68].”
BackgroundThe Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review
Yin, J.-T., Xu, X., Jin, C.-Y., Yuan, X., & Wang, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2202038 · Cited by 15
“synaptic loss and dysfunction in AD [58].”
Saucier, J., Comeau, D., Robichaud, G. A., & Chamard-Witkowski, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1221266 · Cited by 19
“In fact, the dysregulation of glial cell function leads to cognitive impairment associated with numerous neuropathologies, including metabolic syndromes (24) and neurodegenerative diseases such as Parkinson’s (25) and Alzheimer’s (26) diseases.”
BackgroundIsrael, L. L., Braubach, O., Shatalova, E. S., Chepurna, O. M., Sharma, S., Klymyshyn, D., Galstyan, A., Chiechi, A., Cox, A., Herman, D. A., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106307 · Cited by 14
“…system plays an essential role in modulating tissue homeostasis and immune surveillance; dysregulation of this pathway is associated with a number of autoimmune disorders and may contribute to excessive synaptic pruning and loss in neurodegenerative diseases such as AD (Hong et al., 2016).”
Background
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.